FGF-20 Antibody [PE]
Novus Biologicals, part of Bio-Techne | Catalog # AF2547P
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Neutralization, Western Blot
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human FGF-20
Pro3-Thr211
Accession # Q9NP95
Pro3-Thr211
Accession # Q9NP95
Specificity
Detects human FGF‑20 in direct ELISAs and Western blots. In direct ELISAs, less than 40% cross-reactivity with recombinant human (rh) FGF-16 and rhFGF-9 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for FGF-20 Antibody [PE]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: FGF-20
Human FGF-20 is a 23 kDa, 211 aa polypeptide that contains no signal sequence. FGF-20 demonstrates 72% homology with FGF-9, suggesting that it may be secreted in a similar manner to FGF-9.
Long Name
Fibroblast Growth Factor 20
Alternate Names
FGF20
Gene Symbol
FGF20
Additional FGF-20 Products
Product Documents for FGF-20 Antibody [PE]
Product Specific Notices for FGF-20 Antibody [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...